← Back to Search

Focused Ultrasound

Transcranial Focused Ultrasound for Depression and Anxiety

N/A

Waitlist Available

Led By Sheldon Jordan, M.D.

Research Sponsored by Neurological Associates of West Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years of age

Failure to remit with 3 anxiolytics

Timeline

Screening 3 weeks

Treatment Varies

Follow Up after final ultrasound (8 weeks from baseline)

Awards & highlights

Study Summary

This trial will study whether transcranial ultrasound is a safe and effective treatment for patients with depression and anxiety that has not responded to other treatments.

Who is the study for?

This trial is for adults who have tried at least three antidepressants and anxiolytics without improvement, have a diagnosis of Major Depressive Disorder or Generalized/Acute Anxiety Disorder, and score high on anxiety and depression scales.Check my eligibility

What is being tested?

The study is testing the use of transcranial focused ultrasound as a treatment. It's an open label study, meaning everyone knows they're getting the treatment, to see if it helps with severe depression and anxiety.See study design

What are the potential side effects?

Since this summary doesn't provide specific side effects of transcranial focused ultrasound, generally such treatments may cause discomfort at the site of application, headache or dizziness during or after treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have tried 3 different anxiety medications without success.

Select...

I have tried 3 antidepressants without success.

Select...

I have been diagnosed with Major Depressive Disorder.

Select...

I have been diagnosed with Generalized or Acute Anxiety Disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ after final ultrasound (8 weeks from baseline)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~after final ultrasound (8 weeks from baseline)

This trial's timeline: 3 weeks for screening, Varies for treatment, and after final ultrasound (8 weeks from baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Beck Anxiety Inventory

Beck Depression Inventory

Hamilton Anxiety Rating Scale

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: TreatmentExperimental Treatment1 Intervention

All patients enrolled will receive transcranial focused ultrasound. Target location is dependent on patient condition.

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Neurological Associates of West Los AngelesLead Sponsor

25 Previous Clinical Trials

3,860 Total Patients Enrolled

Sheldon Jordan, M.D.Principal InvestigatorNeurological Associates - the Interventional Group

4 Previous Clinical Trials

815 Total Patients Enrolled

Media Library

Transcranial Focused Ultrasound (Focused Ultrasound) Clinical Trial Eligibility Overview. Trial Name: NCT04250441 — N/A

Anxiety Research Study Groups: Treatment

Anxiety Clinical Trial 2023: Transcranial Focused Ultrasound Highlights & Side Effects. Trial Name: NCT04250441 — N/A

Transcranial Focused Ultrasound (Focused Ultrasound) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04250441 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the eligibility criteria for this trial include persons over four decades of age?

"This clinical trial is open to candidates aged 18-93, but there are special studies for both individuals under the age of consent and those over 65 years old. Specifically, 279 studies specifically target minors while 1,202 investigate seniors' response to this medication."

Answered by AI

To what demographic does this research trial offer enrollment?

"To be eligible for the study, applicants must have a diagnosis of depression and their age should fall between 18 and 93 years old. There are 100 participants in total that need to be recruited."

Answered by AI

Is the enrollment period still open for this experiment?

"According to the clinicaltrials.gov entry, this trial is not accepting participants at present. It was first published on November 1st 2018 and last changed August 25th 2022. However, there are 1646 other trials that require volunteers right now."

Answered by AI